Abbott’s Takedown Shakedown. No Libre no more
Over the past 48 hours, numerous Facebook groups across Europe that were unaffiliated with Abbott but provided “User group” services to Freestyle Libre users received […]
Over the past 48 hours, numerous Facebook groups across Europe that were unaffiliated with Abbott but provided “User group” services to Freestyle Libre users received […]
As I mentioned a couple of weeks ago, I received a number of Libre2 and Libre2 Plus devices to try. So far, I’ve only used […]
I’ve now managed to get hold of a Libre2 and a Libre 2 Plus. Well, perhaps more than one of each. So I’ll be sticking […]
If you have type 1 and use social media, you can’t have missed the adverts for the newly CE marked SiBionics GS1 CGM system. They […]
The takeaway is that if you’re using any tool like this, it’s worth considering enabling the smoothing functionality. It may not give you exactly what the sensor is reading right now, but doing so is much less likely to result in accidentally delivering too much insulin. Which is more important to you?
What impact does a botched rollout of an app update have on a CGM provider?
Having had the Libre2 fall off during the first few hours of the “Six of the Best” test, I decided to run One Vs Libre2 […]
As I’ve previously discussed, I’ve been running a side by side trial of the currently available CGM systems in the UK. It focused on those […]
As a headline, this seems like a harsh statement to make. As an observation of the organisation and effectiveness of England’s healthcare model, perhaps less […]
The Libre2 has been available for some time now in both Germany and Norway, and is used by a reasonable number of loopers to drive […]
Copyright © 2024 | WordPress Theme by MH Themes